Olema Pharmaceuticals (OLMA) Earnings Date & Reports
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
OLMA is expected to report earnings to fall 1.64% to -60 cents per share on November 09
Q3'26
Est.
$-0.60
Q2'26
Missed
by $0.06
Q1'26
Beat
by $0.01
Q4'25
Beat
by $0.02
Q3'25
Missed
by $0.02
The last earnings report on August 10 showed earnings per share of -61 cents, missing the estimate of -55 cents. With 1.21M shares outstanding, the current market capitalization sits at 579.23M.